PDL BioPharma, Inc. Shareholders Equity (Total)

Shareholders Equity (Total) of PDLI for past 10 years: annual, quarterly and twelve month trailing (TTM) including Shareholders Equity (Total) growth rates and interactive chart. Shareholder equity, also referred to as shareholders' equity and stockholders' equity, it a corporation's owners' residual claim after debts have been paid. Equity is equal to a firm's total assets minus its total liabilities. It is found on a company's balance sheet and it's the total equity available to common shareholders (after accounting for preferred equity). Also called book value or net book value.


Highlights and Quick Summary

  • Shareholders Equity (Total) for the quarter ending June 29, 2020 was $420 Million (a -24.07% decrease compared to previous quarter)
  • Year-over-year quarterly Shareholders Equity (Total) decreased by -34.11%
  • Annual Shareholders Equity (Total) for 2019 was $593 Million (a -18.7% decrease from previous year)
  • Annual Shareholders Equity (Total) for 2018 was $730 Million (a -13.73% decrease from previous year)
  • Annual Shareholders Equity (Total) for 2017 was $846 Million (a 11.98% increase from previous year)
Visit stockrow.com/PDLI for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Shareholders Equity (Total) of PDL BioPharma, Inc.

Most recent Shareholders Equity (Total)of PDLI including historical data for past 10 years.

Interactive Chart of Shareholders Equity (Total) of PDL BioPharma, Inc.

PDL BioPharma, Inc. Shareholders Equity (Total) for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2020 $420.0 $553.12
2019 $593.28 $637.43 $665.42 $693.78 $593.28
2018 $729.78 $739.39 $712.63 $843.11 $729.78
2017 $845.89 $822.98 $818.8 $762.94 $845.89
2016 $755.42 $753.86 $738.65 $742.53 $755.42
2015 $695.95 $595.96 $527.21 $451.94 $695.95
2014 $460.44 $402.01 $296.66 $202.21 $460.44
2013 $113.49 $52.89 $-1.26 $-93.67 $113.49
2012 $-68.12 $-115.48 $-161.11 $-243.78 $-68.12
2011 $-204.27 $-243.24 $-293.51 $-371.2 $-204.27
2010 $-324.18 $-304.54 $-434.86 $-324.18

Business Profile of PDL BioPharma, Inc.

Sector: Other
Industry: Other
PDL BioPharma, Inc. manages various patents in the United States and internationally. The company's patents cover humanization of antibodies. It also offers notes and other long-term receivables services, as well as engages in the equity investment activities. The company was formerly known as Protein Design Labs, Inc. and changed its name to PDL BioPharma, Inc. in 2006. PDL BioPharma, Inc. was founded in 1986 and is headquartered in Incline Village, Nevada.